KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Gains from Investment Securities (2016 - 2025)

HCA Healthcare (HCA) has disclosed Gains from Investment Securities for 16 consecutive years, with $146.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 39.92% to $146.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $67.0 million, a 74.23% decrease, with the full-year FY2024 number at $115.0 million, changed N/A from a year prior.
  • Gains from Investment Securities was $146.0 million for Q3 2025 at HCA Healthcare, up from -$48.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.3 billion in Q4 2021 to a low of -$854.0 million in Q4 2022.
  • A 5-year average of $136.1 million and a median of $17.5 million in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 3000.0% in 2021, then surged 972.73% in 2022.
  • HCA Healthcare's Gains from Investment Securities stood at $2.3 billion in 2021, then tumbled by 137.64% to -$854.0 million in 2022, then soared by 119.56% to $167.0 million in 2023, then crashed by 86.83% to $22.0 million in 2024, then skyrocketed by 563.64% to $146.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Gains from Investment Securities are $146.0 million (Q3 2025), -$48.0 million (Q2 2025), and -$53.0 million (Q1 2025).